immunity News and Research

RSS

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

A new study reported the outcomes of a clinical trial evaluating the oral vaccine candidate against SARS-CoV-2 developed by Vaxart.

25 Jul 2022

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

Heart damage is common among patients hospitalized with COVID-19, leading many to wonder how the virus affects the heart.

25 Jul 2022

How prepared are we for a widespread monkeypox outbreak?

In a new study, researchers summarized the epidemiology, etiology, clinical presentation, diagnosis and prevention and treatment strategies for monkeypox (MPX) caused by the monkeypox virus (MPXV).

25 Jul 2022

Study provides the crucial antigenic map of SARS-CoV-2 variants of concern

Twenty different COVID-19 variants were effectively identified and neutralized after a third booster, according to the new study for which the University of Surrey provided the crucial antigenic map of variants of concern.

25 Jul 2022

Maternal antibodies may play a key role in protecting infants from congenital HCMV infections

Antibodies that summon virus-engulfing white blood cells may play an important role in protecting infants from potentially serious congenital infection with human cytomegalovirus (HCMV), according to a study led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian.

22 Jul 2022

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

The Omicron variant of the SARS-CoV-2 virus was first detected in South Africa in November 2021. The high level of infectiousness of the virus and its ability to quickly spawn additional variants has also been observed in Germany: Since January 2022 the Omicron variant BA.1 has dominated here, followed in subsequent months by the variant BA.2.

22 Jul 2022

Study examines the maintenance of immunity to SARS-CoV-2 after natural infection or post-vaccination

A new study examined the maintenance of memory B cell responses to SARS-CoV-2, the virus that causes COVID-19, after recovery from natural infection or post-vaccination.

22 Jul 2022

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

As the BA.5 omicron variant continues to spread, health experts are increasingly preparing for a future in which such COVID-19 variants emerge, surge and recede similar to seasonal flu.

21 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Covid-19 vaccine rollout reduced SARS-CoV-2 infection burden in healthcare workers during second wave

The rapid covid-19 vaccine rollout from December 2020 averted infection in a large proportion of NHS hospital workers in England during the second wave of the pandemic, suggests research published by The BMJ today.

21 Jul 2022

Booster vaccination counters the severity of Omicron breakthrough infections

Researchers assessed a panel of seven SARS-CoV-2 vaccines currently available globally and in the United States and immunity acquired through the previous infection against all Omicron subvariants.

21 Jul 2022

COVID vaccines induce memory B and T cells in primary antibody deficient patients

The SARS-CoV-2-specific B- and T-cell response post-COVID-19 primary and booster vaccination in primary antibody deficient patients.

20 Jul 2022

Supplementing diet with amino acid taurine could be a viable nutritional strategy to combat aging

When our cells process the oxygen we breathe and the food we eat every day in order to survive, they generate potentially toxic by-products popularly known as "free radicals".

20 Jul 2022

Scientists find a promising new combination therapy for certain types of lung tumors

Scientists at the Francis Crick Institute have found that using immunotherapy alongside a drug that blocks a common gene mutation in lung cancer could be a promising new combination therapy for certain types of lung tumors.

20 Jul 2022

What is the prevalence of orthopoxviruses across different populations?

In a new study, researchers assessed the prevalence of orthopoxviruses among the general populations of Bolivia, France, Laos, and Mali.

20 Jul 2022

Neutralizing activity of skin-patch delivered subunit vaccine against SARS-CoV-2 variants

A new study involved an analysis of the serum from a previous study to determine neutralizing activity against new variants.

20 Jul 2022

The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines

Researchers compared the durability of vaccine-induced immunity and natural infection against COVID-19.

20 Jul 2022

Machine learning models help forecast immunotherapy response from gut microbiomes

A new research paper was published in Oncotarget on July 19, 2022, entitled, "Predicting cancer immunotherapy response from gut microbiomes using machine learning models."

20 Jul 2022

Marijuana use is higher among US states that have legalized recreational cannabis use

A study at Columbia University Mailman School of Public Health and The City University of New York found that the rates of cannabis use and daily cannabis use have increased across the U.S., and that current cannabis use and daily use are substantially higher among individuals residing in states that have legalized recreational cannabis use, relative to those where cannabis use remains illegal.

20 Jul 2022

immunity News and Research

SARS-CoV-2 oral vaccine candidate found to induce neutralizing mucosal IgA

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

How prepared are we for a widespread monkeypox outbreak?

Study provides the crucial antigenic map of SARS-CoV-2 variants of concern

Maternal antibodies may play a key role in protecting infants from congenital HCMV infections

Antibodies' neutralization efficacy against Omicron variants BA.1 And BA.2 wanes rapidly, study finds

Study examines the maintenance of immunity to SARS-CoV-2 after natural infection or post-vaccination

IUPUI researchers are developing a fast, efficient COVID-19 biosensor

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

A different approach to build a more durable, broadly effective COVID-19 vaccine

Covid-19 vaccine rollout reduced SARS-CoV-2 infection burden in healthcare workers during second wave

Booster vaccination counters the severity of Omicron breakthrough infections

COVID vaccines induce memory B and T cells in primary antibody deficient patients

Supplementing diet with amino acid taurine could be a viable nutritional strategy to combat aging

Scientists find a promising new combination therapy for certain types of lung tumors

What is the prevalence of orthopoxviruses across different populations?

Neutralizing activity of skin-patch delivered subunit vaccine against SARS-CoV-2 variants

The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines

Machine learning models help forecast immunotherapy response from gut microbiomes

Marijuana use is higher among US states that have legalized recreational cannabis use

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News